Null association between insulin-like growth factors, insulin-like growth factor-binding proteins, and prostate cancer in a prospective study

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 10, 2001, Pages 1101-1102

  Lacey, James ^a   Hsing, Ann W ^a   Fillmore, Capri Mara ^a   Hoffman, Sandra ^b   Helzlsouer, Kathy J ^b   Comstock, George W ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ADULT; AGED; ARTICLE; CANCER RISK; GROWTH REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NULL CELL; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; TUMOR GROWTH;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MIDDLE AGED; ODDS RATIO; PROBABILITY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SOMATOMEDINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034793466     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Insulin-like growth factor physiology and cancer risk
2. Serum insulin-like growth factor-1 levels and prostate cancer risk - Interpreting the evidence
3. Plasma insulin-like growth factor-1 and prostate cancer risk: A prospective study
4. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)
5. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study